Beckett Foundation Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00925899
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beckett Foundation

Active Ingredients

Drugs in Phase 3 Trials (1)

melatonin (1 trial)

Drugs in Phase 2 Trials (3)

albumin (Human) (Plasbumin) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

prednisolone (hydeltra) (1 trial)

Drugs in Other Trials (3)

insect protein (1 trial)

pea (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7